• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Someone please post the total number of cuts!













Was this officially announced on e mail today? Working on a pharma blog post. Please help.

From the email: General Med reduction of approximately 1960 positions. Approximately 1630 in primary care (~1550) and NeuroPsych (~80) field sales forces and 330 positions across headquarters support functions in EH. Approximately 125 medical; 125 positions in commercial support and 80 general admin.

Those affected will being being notified April 2, 2012
 




"Novartis to slash nearly 2,000 U.S. jobs"
ZURICH (Reuters) - Novartis AG is slashing nearly 2,000 jobs in the United States ahead of the patent loss of its top-selling blood pressure drug Diovan, the Swiss drugmaker said on Friday, just months after it said would scale back operations in Switzerland.